Smart Partnerships for Biologics: Accelerating Innovation and Localisation in Indonesia’s Biopharma
Indonesia Biopharma Roundtable
Concept
- Identify where Indonesian biologics biopharma face the most friction in the development-to-commercialisation pipeline
- Understand what support is most needed from global and regional solution providers (CDMOs, tech vendors, analytical services, digital platforms, etc.)
- Explore real collaboration models: licensing, co-development, tech transfer, and outsourcing
- Pinpoint actionable steps to create win-win partnerships in biologics development and manufacturing
Highlights
- Gain valuable insights and explore practical applications through scientific talks.
- Explore cutting-edge solutions at our product demonstrations and exhibition.
- Connect & engage with industry experts and peers to discuss innovative strategies for utilizing Sartorius' solutions.
Sessions
Agenda
[8:45]
By IMAPAC
- One Biopharma setting the tone for the discussion by providing an overview of the current state of drug development in Indonesia
- Follow by each Biopharma executive briefly shares:
- Top challenge in drug development process
- The current state of drug development in the company
- The moderator will present some key challenges allowing each vendor 5 minutes to share their insights
- Solution Providers are invited to respond with insights, not sales pitches – focus on problem-solving.
[9:45 – 10:00]
[10:00 – 10:30]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[10:30 – 11:00]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[11:00 – 11:30]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[11:30 – 12:00]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[12:00 – 13:00]
[13:00 – 13:30]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[13:30 – 14:00]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[14:30 – 15:00]
- Each room hosts 1 solution provider & 1 biopharma leader
- No recording or reporting—just genuine business conversations. Think of it like curated “mini boardrooms” where partners explore alignment and possible collaborations.
Each biopharma can be positioned as the room host, guiding conversations around shared goals and capabilities.
[15:30 – 16:00]
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
